Sunday, June 28, 2026
ADVT 
National

Facebook lawsuit settling fee $51M

Darpan News Desk The Canadian Press, 11 Jan, 2024 04:59 PM
  • Facebook lawsuit settling fee $51M

Meta is offering $51 million to settle a class-action lawsuit in four Canadian provinces over the use of some users' images in Facebook advertising. 

The legal action filed by a B.C. woman claimed her image and those of others were used without their knowledge in Facebook's "sponsored stories" advertising program, which is no longer in operation.

MNP Ltd., the court-appointed administrator handling the proposed settlement, says in a statement the agreement needs to be approved by a B.C. Supreme Court judge in March, along with a process to determine class members’ share of the money. 

The lawsuit was expanded outside of B.C. in 2019 to include residents of Saskatchewan, Manitoba and Newfoundland and Labrador.

Sponsored stories ran from January 2011 to May 2014. If someone liked a product under the program, Facebook generated a news feed endorsement using their name and profile photo, but didn't tell them their image was being used.

"The proposed settlement provides that Facebook will pay the all-inclusive sum of $51 million in exchange for a full and final release by the class of all claims in issue in the class-action against Facebook," the statement issued Thursday by MNP said.

Lawyers estimate 4.3 million people who had their real name or photo used in a sponsored story could qualify as part of the Canadian settlement. 

Anyone who wants to object to the proposed settlement has until March 11.

The MNP statement said class members don't need to do anything yet to get compensation. 

"After settlement is approved, a process will be announced setting out the procedure and manner for class members to submit their claims for a share of the settlement funds."

MORE National ARTICLES

EU regulator recommends Pfizer's COVID pill be authorized

EU regulator recommends Pfizer's COVID pill be authorized
In a statement on Thursday, the EU drug regulator said giving the green light to Pfizer's Paxlovoid could help people infected with COVID-19 avoid more serious disease and being hospitalized. EMA's expert committee recommended the pill be given to adults who don't require oxygen and who are at higher risk of severe disease.

EU regulator recommends Pfizer's COVID pill be authorized

Harsh reality of human smuggling business

Harsh reality of human smuggling business
RCMP found the bodies of a man, a woman, a teen and a baby last week near Emerson, Man. Police believe they had tried to cross into the United States during a heavy snowstorm in freezing temperatures.

Harsh reality of human smuggling business

COVID hospitalizations continue to rise

COVID hospitalizations continue to rise
Dr. Theresa Tam says targeted testing policies and reduced testing continue to underestimate the number of true infections, noting severe illness trends are still rising in most jurisdictions and hospitalization rates are increasing across all age groups.

COVID hospitalizations continue to rise

CRA sends new round of letters to CERB recipients

CRA sends new round of letters to CERB recipients
It's the second time the agency is mailing Canada Emergency Response Benefit recipients as part of a process to verify the eligibility of the millions of Canadians who received the $500-a-week benefit.

CRA sends new round of letters to CERB recipients

Truck convoy expected to delay traffic in GTA: OPP

Truck convoy expected to delay traffic in GTA: OPP
OPP say the convoy, which started in British Columbia, is expected to be coming through the region until Saturday — the day of the so-called "freedom rally" on Parliament Hill.

Truck convoy expected to delay traffic in GTA: OPP

Trudeau isolating after COVID-19 exposure

Trudeau isolating after COVID-19 exposure
Trudeau said the result of a rapid antigen test he took was negative, but he is following local public health rules and isolating for five days. He said he will be working from home during that stretch.

Trudeau isolating after COVID-19 exposure